{"id":"https://openalex.org/W2182181585","doi":null,"title":"Liposomes ameliorate Crizotinib- and Nilotinib-induced inhibition of the cardiac IKr channel and QTc prolongation.","display_name":"Liposomes ameliorate Crizotinib- and Nilotinib-induced inhibition of the cardiac IKr channel and QTc prolongation.","publication_year":2014,"publication_date":"2014-09-01","ids":{"openalex":"https://openalex.org/W2182181585","mag":"2182181585","pmid":"https://pubmed.ncbi.nlm.nih.gov/25202051"},"language":"en","primary_location":{"id":"pmid:25202051","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25202051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085377681","display_name":"George M. Shopp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George M Shopp","raw_affiliation_strings":["Shopp Nonclinical Consulting LLC, Boulder, CO, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shopp Nonclinical Consulting LLC, Boulder, CO, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110196536","display_name":"Lawrence Helson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097497","display_name":"SignPath Pharma (United States)","ror":"https://ror.org/00qdzme95","country_code":"US","type":"company","lineage":["https://openalex.org/I4210097497"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Helson","raw_affiliation_strings":["SignPath Pharma, Quakertown, PA, U.S.A lhelson@comcast.net"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SignPath Pharma, Quakertown, PA, U.S.A lhelson@comcast.net","institution_ids":["https://openalex.org/I4210097497"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Annie Bouchard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annie Bouchard","raw_affiliation_strings":["IPS Therapeutique Inc., Sherbrooke, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPS Therapeutique Inc., Sherbrooke, QC, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009935187","display_name":"Dany Salvail","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dany Salvail","raw_affiliation_strings":["IPS Therapeutique Inc., Sherbrooke, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IPS Therapeutique Inc., Sherbrooke, QC, Canada","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101595684","display_name":"Muhammad Majeed","orcid":"https://orcid.org/0000-0002-9133-0296","observed_orcids":["https://orcid.org/0000-0002-9133-0296"]},"institutions":[{"id":"https://openalex.org/I2802863593","display_name":"Chrysler (Canada)","ror":"https://ror.org/041p8ws46","country_code":"CA","type":"company","lineage":["https://openalex.org/I2802863593","https://openalex.org/I4405253751","https://openalex.org/I4405256301","https://openalex.org/I4405257372"]},{"id":"https://openalex.org/I4210093451","display_name":"Windsor Regional Hospital","ror":"https://ror.org/0057mbc31","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210093451"]},{"id":"https://openalex.org/I4210101092","display_name":"Windsor Clinical Research","ror":"https://ror.org/012kq8z96","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210101092"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Muhammad Majeed","raw_affiliation_strings":["Sabinsa Corporation, East Windsor, NJ, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sabinsa Corporation, East Windsor, NJ, U.S.A","institution_ids":["https://openalex.org/I2802863593","https://openalex.org/I4210093451","https://openalex.org/I4210101092"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0702,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.7834249,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"34","issue":"9","first_page":"4733","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.9477999806404114,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.038600001484155655,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.8450000286102295},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.996999979019165},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":1.0},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.9139999747276306},{"id":"https://openalex.org/keywords/herg-channel","display_name":"hERG","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-induced-cardiotoxicity","display_name":"drug-induced cardiotoxicity","score":0.8309999704360962},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.7609999775886536},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.48500001430511475},{"id":"https://openalex.org/keywords/rabbit-heart","display_name":"rabbit heart","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.8656290769577026},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.7815341949462891},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.7751697897911072},{"id":"https://openalex.org/C2779362680","wikidata":"https://www.wikidata.org/wiki/Q905000","display_name":"hERG","level":3,"score":0.7743170261383057},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7173590660095215},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5411668419837952},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.5385651588439941},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.26854372024536133},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.26577141880989075},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.2615959644317627},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22936779260635376},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.18935194611549377},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000072237","descriptor_name":"ERG1 Potassium Channel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077547","descriptor_name":"Crizotinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006329","descriptor_name":"Heart Conduction System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051638","descriptor_name":"Ether-A-Go-Go Potassium Channels","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:25202051","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25202051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2182181585","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25202051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1855426176","https://openalex.org/W1971087918","https://openalex.org/W1972042487","https://openalex.org/W1989217478","https://openalex.org/W1993428519","https://openalex.org/W2038701978","https://openalex.org/W2092052197","https://openalex.org/W2169558404"],"related_works":["https://openalex.org/W2524270742","https://openalex.org/W7167231074","https://openalex.org/W7166144570","https://openalex.org/W1971087918","https://openalex.org/W2326624970","https://openalex.org/W3010074778","https://openalex.org/W7155392825","https://openalex.org/W1855426176","https://openalex.org/W4392665143","https://openalex.org/W2328187422"],"abstract_inverted_index":{"Crizotinib":[0,85],"(Xalkori\u00ae)":[1],"and":[2,18,39,79,86,111],"nilotinib":[3,80,87,129,187],"(Tasigna\u00ae)":[4],"are":[5],"tyrosine":[6],"kinase":[7],"inhibitors":[8],"approved":[9],"for":[10],"the":[11,50,59,75,82,106,112,120,141,170,175,178,200,203,206],"treatment":[12],"of":[13,77,146,169,177,211],"non-small":[14],"cell":[15],"lung":[16],"cancer":[17],"chronic":[19],"myeloid":[20],"leukemia,":[21],"respectively.":[22],"Both":[23],"have":[24,42],"been":[25,43],"shown":[26,44],"to":[27,45,68,156,196],"result":[28],"in":[29,37,90,92,140,164,219],"electrocardiogram":[30],"rate-corrected":[31],"Q-wave":[32],"T-wave":[33],"interval":[34],"(QTc)":[35],"prolongation":[36],"humans":[38],"animals.":[40],"Liposomes":[41],"ameliorate":[46],"drug-induced":[47],"effects":[48,145,176,204],"on":[49,81,205],"cardiac-delayed":[51],"rectifier":[52],"K(+)":[53],"current":[54],"(IKr,":[55],"KV11.1),":[56],"coded":[57],"by":[58],"human":[60,97],"ether-a-go-go-related":[61],"gene":[62],"(hERG).":[63],"This":[64],"study":[65],"was":[66,136],"undertaken":[67],"determine":[69],"if":[70],"liposomes":[71,173,192,201,218],"would":[72],"also":[73],"decrease":[74,139,224],"effect":[76],"crizotinib":[78,127,157,185,197],"IKr":[83,94,142],"channel.":[84],"were":[88,109,117,124,131,154,161,193],"tested":[89],"an":[91],"vitro":[93],"assay":[95],"using":[96],"embryonic":[98],"kidney":[99],"(HEK)":[100],"293":[101,122],"cells":[102,123],"stably":[103],"transfected":[104],"with":[105,126,133,172,184,221],"hERG.":[107],"Dose-responses":[108],"determined":[110],"50%":[113],"inhibitory":[114,144],"concentrations":[115],"(IC50s)":[116],"calculated.":[118],"When":[119,150,191],"HEK":[121],"treated":[125],"or":[128,158,186,198,216],"that":[130],"mixed":[132],"liposomes,":[134],"there":[135,160],"a":[137],"significant":[138,162],"channel":[143],"these":[147],"two":[148],"drugs.":[149,179],"isolated,":[151],"rabbit":[152],"hearts":[153],"exposed":[155],"nilotinib,":[159,199],"increases":[163],"QTc":[165,189,207],"prolongation.":[166,190],"Mixing":[167],"either":[168],"drugs":[171],"ameliorated":[174],"Rabbits":[180],"dosed":[181],"intravenously":[182],"(IV)":[183],"showed":[188],"injected":[194],"prior":[195],"decreased":[202],"interval.":[208],"The":[209],"use":[210],"liposomal":[212],"encapsulated":[213],"QT-prolongation":[214],"agents,":[215],"giving":[217],"combination":[220],"drugs,":[222],"may":[223],"their":[225],"cardiac":[226],"liability.":[227]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}